|
|
|
Insider
Information: |
Stoll Roger G Phd |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
109,309 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$66,849 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
109,309 |
|
|
Total
Value |
$66,849 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
RespireRx Pharmaceuticals Inc |
RSPI |
Chief Executive Office... |
2008-04-22 |
100,000 |
2005-03-14 |
0 |
Premium* |
|
Chelsea Therapeutics Internation... |
CHTP |
Director |
2014-06-23 |
0 |
2008-05-30 |
0 |
Premium* |
|
Delcath Systems Inc |
DCTH |
Director |
2020-05-08 |
9,309 |
2009-11-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
27 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
27 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|